drugset / Trial / NCT04370145

Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy

NCT04370145

RandomizedParallel-groupOpen-labelTreatment

Summary

Application of multi-center, prospective study on the severity of postoperative cholangitis biliary atresia classification, according to the degree of cholangitis targeted therapy, to improve the therapeutic effect of postoperative cholangitis biliary atresia, decrease the overuse of antibiotics related complications.

Timeline

Start
2021-05-01
Primary completion
2021-10-01
Completion
2022-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Meropenem Small molecule 20 mg/kg Intravenous
Subject Sulperazon Unknown 100 mg/kg Intravenous
Subject Teicoplanin Other / unclassified 10 mg/kg Intravenous

Indications